Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair®): A bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions

Expert Opinion on Drug Metabolism and Toxicology

Volumn 4, Issue 11, 2008, Pages 1449-1454

  Buchsel, Patricia C ^a  

^a SEATTLE UNIVERSITY   (United States)

Author keywords

Bioadherent gel; Gelclair ; Glycyrrhetinic acid; Nutritional deficiency; Oral mucositis; Pain; Polyvinylpyrrolidone sodium hyaluronate

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYDAMINE; GELCLAIR; GLYCYRRHETINIC ACID; HYALURONIC ACID; IBUPROFEN; OPIATE; OXETACAINE; PLACEBO; POVIDONE; SUCRALFATE; UNCLASSIFIED DRUG;

ANALGESIA; BURNING SENSATION; CANCER PATIENT; CANCER RADIOTHERAPY; CARBON DIOXIDE LASER; CLINICAL TRIAL; DENTISTRY; DISEASE DURATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LASER SURGERY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; MOUTH LESION; MOUTH MUCOSA; MOUTH PAIN; MOUTHWASH; MUCOSA INFLAMMATION; ONCOLOGY; PEER REVIEW; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; WOUND HEALING;

ADHESIVES; ANIMALS; DRUG COMBINATIONS; GELS; HUMANS; HYALURONIC ACID; MOUTH DISEASES; MOUTH MUCOSA; PAIN; POVIDONE; STOMATITIS;

EID: 56849092690     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.4.11.1449     Document Type: Review

References (25)

1. American Cancer Society: ACS News Center. Mouth sores painful for patients: new scoring system to aid in treating mouth scores. Available at: http://www.cancer.org/docroot/ NSW_lx_Mouth_Sores_painful_for_Patients.asp [assessed July 9 2008]
2. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systemic literature review Radiother Oncol 2003;66:253-62
3. Sonis S. Oral mucositis in cancer therapy. J Support Oncol 2004;6(Suppl 3):3-8
4. Stiff PJ. Continuing progress for a continuing need. Support Care Oncol 2007;(Suppl 2)
5. Rose-Ed AM, Bellm LA, Epstein JB, et al. Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs 2002;25:468-9
6. Speilberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers N Eng J M 2004;51:2590-8
7. Keefe DM, Schubert MM, Elting LS, et al. Association of Supportive Care in Cancer and the International Society for Oral Oncology Cancer 2007;109(5)820-3
8. Mahood DF, Dosoe AM, Loprinzi CL, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991;93:449-90
9. McCarthy GM, Awde JD, Ghandi H, et al. Risk factors assoiciated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 1998;34(6):484-90
10. Lilleby K, Garcia P, Gooley T. et al. A prospective randomized study of cryotherapy during administration of high dose melphalan to decrease the severity and duration of oral mucositis in patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Bone Marrow Trans 2006;37:1031-5
11. Gelclair® [package insert] (2006). EKR Therapeutics, Inc, Cedar Knolls, New Jersey
12. Zaleski KJ, Dolodka T, Cawes-Bentley C, et al. Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection 2006; Antimicrob Agents Chemother Am Soc Microbio 2006;3856-60
13. 2 laser. Int J Oral Maxillofac Surg 2006; 35:514-7
14. Lee, JS, Young-Sunm C, Lee JW, et al. Preparation of wound dressing using hydrogel polyurethane foam. Trends Biomater Artif Orig 2001;15:4-6
15. National Cancer Institute (2007). Pilot study of polyvinylpyrrolidone-sodium hyaluronate gel in reducing the pain of oral mucositis in pediatric patients with cancer. Available from: www.cancer.gov/PDQ® [Last accessed July 6 2008] clinical trials
16. Bensinger W, Schubert M, Ang K, et al. (2008). NCCN Task Force: prevention and management of mucositis J Nat Compr Cancer Netw 2008;6(suppl)51-21
17. Inoue H, Shibata S, Koshihar Y. Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear odeman. Brit J Pharm 1989:204-10
18. 14C]povidone after oral administration to the rat. Food Chem Toxic 1987;25:241-3
19. Bastow ER, Byers S, Golub SB, et al. Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 2008;65:395-413
20. De Cordi M, D'andrea P. Giorgiutti E. Gelclair, potentially an efficacious treatment for chemotherapy-induced mucositis. Italian Tumour League III Congress for Professional Oncology Nurses; 10-12 October 2001 Conegliano
21. Innocenti M, Moscatellig G, Lopez S, et al. Efficacy of Gelcair® in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study. J Pain Symptom Manag 2002;24:456-45
22. Barber C, Powell R, Ellis A, et al. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair; a preliminary, double centre, randomized controlled on patients with radiotherapy-induced oral mucositis Support Care Cancer 2007;15:427-40
23. Flook C, Calman F, Mant M, et al. Gelclair vs benzydamine in a randomized controlled study in patients with oral mucositis due to radical radiotherapy. Support Car Cancer 2005;13:401-83
24. Epstein JB, Silverman S Jr, Paggiarino DA, et al. Benzydamine HCI for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92:875
25. Cawley MM, Benson L. Current trends in managing oral mucositis. Clin J Oncol Nurs 2005;9(5):584-92